Suscribirse

Seven-point checklist for dermatoscopy: Performance during 10 years of prospective surveillance of patients at increased melanoma risk - 24/04/13

Doi : 10.1016/j.jaad.2009.08.049 
Holger A. Haenssle, MD a, , Bianca Korpas a, Christian Hansen-Hagge a, Timo Buhl, MD a, Kjell M. Kaune, MD a, Albert Rosenberger, MD b, Ullrich Krueger, MD a, Michael P. Schön, MD a, Steffen Emmert, MD a
a Department of Dermatology, Georg August University Göttingen, Göttingen, Germany 
b Department of Genetic Epidemiology, Georg August University Göttingen, Göttingen, Germany 

Reprint requests: Holger A. Haenssle, Department of Dermatology, Georg August University Göttingen, Von Siebold Strasse 3, D 37075 Göttingen, Germany.

Abstract

Background

The retrospectively developed 7-point checklist is one of the most applicable dermatoscopic algorithms for clinical use. However, until today no prospective data on the diagnostic performance of this algorithm were reported.

Objective

Our aim was to assess the sensitivity, specificity, and diagnostic accuracy of the 7-point checklist in the setting of a prospective long-term study.

Methods

Patients at increased melanoma risk (n = 688) were screened at regular intervals by naked-eye examination, the dermatoscopic 7-point checklist, and digital dermatoscopy follow-up (10-year study interval).

Results

We detected 127 melanomas including 50 melanomas in situ. The mean Breslow thickness of invasive melanomas was 0.57 mm. A total of 79 melanomas displayed the 7-point checklist melanoma threshold of 3 or more points (62% sensitivity, compared with 78%-95% in retrospective settings). In all, 48 melanomas scored fewer than 3 points and were excised because of complementary information (eg, lesional history, dynamic changes detected by digital dermatoscopy). The specificity of the 7-point checklist was 97% (compared with 65%-87% in retrospective settings). Regression patterns, atypical vascular patterns, and radial streaming were associated with the highest relative risk for melanoma (odds ratio 3.26, 95% confidence interval 2.05-5.16; odds ratio 3.04, 95% confidence interval 1.70-5.46; odds ratio 2.91, 95% confidence interval 1.64-5.15; P < .0003, respectively). Melanomas thicker than 0.5 mm exhibited significantly more regression patterns and atypical vascular patterns (P < .02). The malignant versus benign ratio for all excised lesions was 1:8.6 (127 melanomas, 1092 nonmelanomas).

Limitations

Calculation of the specificity was a limitation. True negative lesions were defined by a score less than 3 points and either the histopathological diagnosis of nonmelanoma or the absence of dynamic changes during digital dermatoscopy follow-up (nonexcised, nonsuspicious, no change).

Conclusions

The 7-point checklist for dermatoscopy was less sensitive but highly specific in this prospective clinical setting. Complementary information clearly increased the sensitivity. Regression patterns or radial streaming in nevi of patients at high risk should raise a higher melanoma suspicion than might be concluded from retrospective studies.

El texto completo de este artículo está disponible en PDF.

Key words : atypical mole syndrome, atypical mole and multiple melanoma syndrome, dermatoscopy, melanoma, 7-point checklist


Esquema


 Supported in part by the Cancer Society of Lower Saxony (Niedersächsische Krebsgesellschaft e.V., Hannover, Germany). The FotoFinder dermatoscope used in this study is a donation of Teachscreen Software GmbH (Bad Birnbach, Germany) to the University Hospital Göttingen.
 Conflicts of interest: None declared.


© 2010  American Academy of Dermatology, Inc.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 62 - N° 5

P. 785-793 - mai 2010 Regresar al número
Artículo precedente Artículo precedente
  • Change of Address
| Artículo siguiente Artículo siguiente
  • Use of and beliefs about total body photography and dermatoscopy among US dermatology training programs: An update
  • Vitaly Terushkin, Susan A. Oliveria, Ashfaq A. Marghoob, Allan C. Halpern

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.